Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 60 years; 2. All the included populations voluntarily receive the new crown vaccination and voluntarily join the study; 3. Healthy volunteers who meet the requirements for vaccination.
Exclusion criteria
Exclusion criteria: 1. Those who are allergic to any ingredient in the vaccine; 2. Those who have experienced severe allergic reactions to vaccines in the past, such as acute allergic reactions, urticaria, skin eczema, dyspnea, angioedema or abdominal pain; 3. People with fever, severe acute disease, acute attack of chronic disease; 4. Those who have recovered from new coronary pneumonia or asymptomatic infection; 5. Couples who have a family plan within 3 months of vaccination, as well as pregnant women and lactating women; 6 People with history or family history of convulsions, epilepsy, encephalopathy or mental illness; 7. People with uncontrolled epilepsy and other progressive neurological diseases, and those with a history of Guillain-Barré syndrome; 8. Has been diagnosed with congenital or acquired immunodeficiency, HIV infection, lymphoma, leukemia or other autoimmune diseases; 9. Those who are known or suspected of suffering from severe respiratory diseases, severe cardiovascular diseases, liver and kidney diseases, and malignant tumors; 10. Those who use immunomodulators such as anti-tumor drugs; 11. Those who are deemed unsuitable for vaccination by clinicians or vaccination staff; 12. The vaccinators who refused to join this study; 13. Those who withdrew from the study without any reason iduring the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum IgG;Serum IgM;Proteinomics(blood, urine and fecal);T cell immune subgroup;Neutralizing antibody; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammation markers; | — |
Countries
China
Contacts
Xinqiao Hospital, Army Military Medical University